CD19 CAR T-cell therapy in relapsed TCF3-HLF-positive B-cell acute lymphoblastic leukemia

被引:0
|
作者
Yao, Yao [1 ,2 ]
Zhou, Jin [1 ,2 ]
Li, Yanting [1 ,2 ]
Shi, Sensen [1 ,2 ]
Yu, Lei [3 ]
Wu, Depei [1 ,2 ]
Wang, Ying [1 ,2 ]
机构
[1] Soochow Univ, Jiangsu Inst Hematol, Natl Clin Res Ctr Hematol Dis, Affiliated Hosp 1, Suzhou, Peoples R China
[2] Soochow Univ, Inst Blood & Marrow Transplantat, Collaborat Innovat Ctr Hematol, Suzhou, Peoples R China
[3] Shanghai Unicar Therapy Biomed Technol Co Ltd, Shanghai, Peoples R China
关键词
YOUNG-ADULTS; CHILDREN;
D O I
10.1007/s00277-024-05945-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:6031 / 6033
页数:3
相关论文
共 50 条
  • [31] CD4+CD25+CD127low regulatory T cells associated with the effect of CD19 CAR-T therapy for relapsed/refractory B-cell acute lymphoblastic leukemia
    Pan, Ying
    Wang, Huiping
    An, Furun
    Wu, Fan
    Tao, Qianshan
    Li, Yingwei
    Ruan, Yanjie
    Zhai, Zhimin
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 96
  • [32] Safety of Axicabtagene Ciloleucel CD19 CAR T-Cell Therapy in Elderly Patients with Relapsed or Refractory Large B-Cell Lymphoma
    Sano, Dahlia
    Nastoupil, Loretta J.
    Fowler, Nathan H.
    Fayad, Luis
    Hagemeister, F. B.
    Lee, Hun Ju
    Samaniego, Felipe
    Wang, Michael
    Rodriguez, Maria Alma
    Iyer, Swaminathan P.
    Parmar, Simrit
    Steiner, Raphael
    Nair, Ranjit
    Adkins, Sherry
    Arafat, Sara
    Rao, Ahalya
    Vallejo, Liliana
    Hawkins, Misha
    Chen, Yiming
    Westin, Jason R.
    Neelapu, Sattva S.
    BLOOD, 2018, 132
  • [33] CD19/CD22 chimeric antigen receptor T-cell therapy for refractory acute B-cell lymphoblastic leukemia with FLT3-ITD mutations
    Aiyun Jin
    Jingjing Feng
    Guoqing Wei
    Wenjun Wu
    Luxin Yang
    Huijun Xu
    Yanlei Zhang
    Jiazhen Cui
    Alex Hongsheng Chang
    Yongxian Hu
    He Huang
    Bone Marrow Transplantation, 2020, 55 : 717 - 721
  • [35] CD19/CD22 chimeric antigen receptor T-cell therapy for refractory acute B-cell lymphoblastic leukemia with FLT3-ITD mutations
    Jin, Aiyun
    Feng, Jingjing
    Wei, Guoqing
    Wu, Wenjun
    Yang, Luxin
    Xu, Huijun
    Zhang, Yanlei
    Cui, Jiazhen
    Chang, Alex Hongsheng
    Hu, Yongxian
    Huang, He
    BONE MARROW TRANSPLANTATION, 2020, 55 (04) : 717 - 721
  • [36] Checkpoint Inhibitors Augment CD19-Directed Chimeric Antigen Receptor (CAR) T Cell Therapy in Relapsed B-Cell Acute Lymphoblastic Leukemia
    Li, Amanda M.
    Hucks, George E.
    Dinofia, Amanda M.
    Seif, Alix E.
    Teachey, David T.
    Baniewicz, Diane
    Callahan, Colleen
    Fasano, Christina
    McBride, Beth
    Gonzalez, Vanessa
    Nazimuddin, Farzana
    Porter, David L.
    Lacey, Simon F.
    June, Carl H.
    Grupp, Stephan A.
    Maude, Shannon L.
    BLOOD, 2018, 132
  • [37] Bone marrow fibrosis is associated with non-response to CD19 CAR T-cell therapy in B-acute lymphoblastic leukemia
    Anil, Joshua
    Alnemri, Ahab
    Lytle, Andrew
    Lockhart, Brian
    Anil, Ashley E.
    Baumgartner, Michael
    Gebre, Kirubel
    Mcferran, Jared
    Grupp, Stephan A.
    Rheingold, Susan R.
    Pillai, Vinodh
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (12) : 1888 - 1897
  • [38] CAR T-Cell Therapy in Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia/Lymphoma: A Retrospective Study
    Zhao, Liping
    Zhou, Qi
    Chen, Chen
    Ling, Zhuojun
    Wang, Kai
    Wu, Fan
    Xu, Jinlong
    Duan, Jiajia
    Wang, Zelin
    Wang, Quangang
    Pan, Jing
    BLOOD, 2023, 142
  • [39] Mechanisms of Relapse After CD19 CAR T-Cell Therapy for Acute Lymphoblastic Leukemia and Its Prevention and Treatment Strategies
    Xu, Xinjie
    Sun, Qihang
    Liang, Xiaoqian
    Chen, Zitong
    Zhang, Xiaoli
    Zhou, Xuan
    Li, Meifang
    Tu, Huilin
    Liu, Yu
    Tu, Sanfang
    Li, Yuhua
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [40] Role of CAR-T cell therapy in B-cell acute lymphoblastic leukemia
    Greinix, Hildegard T.
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2020, 13 (01) : 36 - 42